Non-Current Assets
Equity Method Investments
Medtronic Equity Method Investments increased by 8.8% to $730.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.8%, from $809.00M to $730.00M.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025
How to read this metric
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
Detailed definition
These are investments in entities where the company exercises significant influence but does not have full control. The...
Peer comparison
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
Metric ID:
equity_method_investmentsHistorical Data
6 periods
| Q2 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $859.00M | $809.00M | $705.00M | $697.00M | $671.00M | $730.00M |
| QoQ Change | — | -5.8% | -12.9% | -1.1% | -3.7% | +8.8% |
| YoY Change | — | — | -17.9% | — | — | -9.8% |
Range$671.00M – $859.00M
CAGR-12.2%
Avg YoY Growth-13.8%
Median YoY Growth-13.8%
Equity Method Investments at Other Companies
Frequently Asked Questions
- What is Medtronic's equity method investments?
- Medtronic (MDT) reported equity method investments of $730.00M in Q1 2026.
- How has Medtronic's equity method investments changed year-over-year?
- Medtronic's equity method investments decreased by 9.8% year-over-year, from $809.00M to $730.00M.
- What does equity method investments mean?
- The value of investments in other companies where the firm has significant influence but not total control.